Header Logo

Connection

MICHAEL VOLK to Phenylurea Compounds

Back to Details
This is a "connection" page, showing publications MICHAEL VOLK has written about Phenylurea Compounds.
MICHAEL VOLK
Connection Strength
0.021
Phenylurea Compounds
  1. Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety. Hepatology. 2010 Jan; 51(1):165-73.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.